| Martina Rose Pojeta, RPH | |
|
372 Towne Centre Dr., Abingdon, VA 24210 | |
| (276) 628-3233 | |
| Not Available |
| Full Name | Martina Rose Pojeta |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 372 Towne Centre Dr., Abingdon, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932317484 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0202010432 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Martina Rose Pojeta, RPH 20246 Heron Cir, Abingdon, VA 24211-7618 Ph: (276) 628-3790 | Martina Rose Pojeta, RPH 372 Towne Centre Dr., Abingdon, VA 24210 Ph: (276) 628-3233 |
News Archive
In a study published in the Journal of Clinical Investigation Insight, Saint Louis University scientists have found that elevated levels of chlorinated lipids are linked to sepsis, lung injury and death. The finding may offer a way to diagnosis and treat sepsis earlier, saving lives and avoiding serious side effects.
The Bill & Melinda Gates Foundation today announced that it will commit $50 million to support the scale up of emergency efforts to contain the Ebola outbreak in West Africa and interrupt transmission of the virus.
Fatal snakebites are a bigger-than-acknowledged global health problem that has been vastly under-reported, according to research presented today at the American Society of Tropical Medicine and Hygiene's (ASTMH) annual meeting.
Investigators discover cellular mechanisms that may impact the decline of both innate and adaptive immune functions that increase the susceptibility to various infectious agents, cancer and diseases in the elderly say experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.
Threshold Pharmaceuticals, Inc., today announced that it has initiated a Phase 1 clinical trial of TH-302 in patients with advanced leukemias. TH-302 is a proprietary Hypoxia-Activated Prodrug (HAP) that specifically targets tumor hypoxia.
› Verified 4 days ago
Angela Marie Cooper, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16000 Johnston Memorial Dr, Abingdon, VA 24211 Phone: 276-258-3050 | |
Dr. James Justin Wimmer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 668 W Main St, Abingdon, VA 24210 Phone: 276-628-2300 | |
Michael Justice, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Food City Circle, Abingdon, VA 24210 Phone: 276-623-5100 | |
James Russell Belcher, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 396 Town Centre Dr, Abingdon, VA 24210 Phone: 276-628-2580 | |
Justin Greer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16000 Johnston Memorial Dr, Abingdon, VA 24211 Phone: 276-258-3050 | |
Kevin Scott Wood, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 795 Cummings Street, Abingdon, VA 24211 Phone: 276-258-5251 Fax: 276-258-5289 | |
Dr. Derek Webb, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 396 Towne Center Dr, Abingdon, VA 24210 Phone: 276-628-2580 Fax: 276-628-8043 |